Douglas F. Easton

University of Cambridge

Full Professor(heuristic)

BRCA gene mutations in cancer · Genetics

h-index179

i10-index774

Publications1,160

Citations138,864

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 63

Supplementary Methods from Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
2025-11-26
Supplementary Table S1 from Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
2025-11-26
Supplementary Figure from Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations
2025-11-26
Supplementary Table S2 from Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
2025-11-26
Data from Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations
2025-11-26
Supplementary Table S4 from Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
2025-11-26
Supplementary Table S3 from Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
2025-11-26
Supplementary Data from Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations
2025-11-26
Table 3 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Table 2 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Table 1 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 3 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 6 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 9 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 5 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 8 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 1 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 12 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 11 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03
Supplemental Table 10 from Breast Cancer Polygenic Risk Score Associated with Outcomes after <i>In Situ</i> Breast Disease
2025-11-03

Open author page on OpenAlex →